AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NYSE Stocks In The News.(A)
Byline: Jonah Keri
Barr Laboratories moved sideways from August until early February, then dropped into a correction. The stock took out its 50- and 200-day moving averages en route to a 44% fall. But that was in line with the market's steep drop. The stock has zoomed back, and is now 7% off its high.
Barr has clawed its way back near its previous high, but may not be ready tobreak out yet. The stock has soared higher in 11 of the last 12 days without pausing to consolidate its gains. It may benefit from a downward-sloping handleto shake out the last weak holders before clearing its base.
After a rough late 1999 and early 2000, Barr has started to turn its fundamentals around. In the last four quarters, sales growth has jumped from flat to 13%. Profit growth remains bumpy. It's ranged from flat to 19% in the last five quarters. It was 2% last ...
- Barr Signs Letter of Intent to Acquire Currently Marketed Wyeth Products.
- Press release article from: PR Newswire December 2, 2002 700+ words
Barr Also Expects to Receive License To Develop, Market Late Stage Oral Contraceptive Product Barr Laboratories, Inc. and Wyeth today announced that they have signed a letter of intent for Barr to acquire the rights to three currently marketed...
- Barr and Galen Sign Letters of Intent for Barr to Acquire Exclusive Rights to...
- Press release article from: PR Newswire September 11, 2003 700+ words
Barr Laboratories, Inc. and Galen Holdings PLC...that they have signed a letter of intent for Barr to acquire from Galen the exclusive rights...a settlement of pending litigation between Barr and Galen regarding Galen's femhrt(R...
- Barr and Galen Sign Letters of Intent for Barr to Acquire Exclusive Rights to...
- Press release article from: PR Newswire September 11, 2003 700+ words
Barr Laboratories, Inc. and Galen Holdings PLC...that they have signed a letter of intent for Barr to acquire from Galen the exclusive rights...a settlement of pending litigation between Barr and Galen regarding Galen's femhrt(R...
- Barr agrees to acquire three medications from Wyeth. (Government).(Barr...
- Magazine article from: Chain Drug Review December 16, 2002 700+ words
POMONA, N.Y. -- Barr Laboratories Inc. has signed a letter...three currently marketed Wyeth products. Barr also expects to receive a license to develop...then Wyeth-Ayerst Laboratories Inc. (Barr and Duramed merged in October 2001...
- Barr and PLIVA sign agreement to develop generic G-CSF.
- Newspaper article from: BIOTECH Patent News March 1, 2005 700+ words
Barr Pharmaceuticals, Inc. (Woodcliff Lake, NJ) and PLIVA d.d. announced that Barr's subsidiary, Barr Laboratories, Inc., and PLIVA's subsidiaries, PLIVA Croatia Ltd...
- Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R)...
- Press release article from: PR Newswire June 4, 2007 700+ words
WOODCLIFF LAKE, N.J., June 4 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. ("Barr"), and Eli Lilly & Company ("Lilly") voluntarily stipulated...
- Barr Pharmaceuticals Generics Company Intelligence Report Reveals Teva...
- Press release article from: M2 Presswire June 19, 2009 700+ words
...19 June 2009-Research and Markets: Barr Pharmaceuticals Generics Company Intelligence...Pharmaceutical Industries Plan to Acquire Barr in a Deal Worth US$7.46 Billion(C...researchandmarkets.com/research/2b296f/barr_pharmaceutica) has announced the addition...
- BARR LABORATORIES ANNOUNCE RESTRUCTURING
- Press release article from: PR Newswire April 29, 1992 700+ words
BARR LABORATORIES ANNOUNCE RESTRUCTURING POMONA, N.Y., April 29 /PRNewswire/ -- Barr Laboratories (AMEX: BRL) announced a restructuring...Drug Administration (FDA) actions against Barr over the past 12 months, which have prevented...